03 B Cells

_arrow-up-right..

BCR

_arrow-up-right..

  • FAB: fragment antigen binding

  • FC: constant

  • Made of monomer IgM antibody

  • purple: variable regions. Vary from 1 B cell to another

  • light chain: 1 constant region; heavy chain 3 constant regions

  • variable regions end in nitrogen groups; constant end in carboxyl group

  • Connected by disulfide bridges

  • macrophage Fc/protein A binds CH2-CH3 region

Heavy chain

_arrow-up-right..

Activation

_arrow-up-right..

_arrow-up-right..

  1. B cell crosslinked by antigen

  2. Second signal required in addition to crosslinking

  3. MHC 2 binds TCR and CD4

  4. CD40 binds CD40L: class switching

  5. B7 binds CD28: T cytokine secretion

_arrow-up-right..

  • macrophage antigen presenting instead

T Independent

_arrow-up-right..

  • so many antigen on surface, B cell activated without T

_arrow-up-right..

Conjugated Vaccine

_arrow-up-right..

Surface Proteins

_arrow-up-right..

  • CD21 receptor for complement, receptor for EBV

Antibody

_arrow-up-right..

_arrow-up-right..

Protein A

_arrow-up-right..

  • prevents opsonization:

Class Switching

_arrow-up-right..

  • only change Fc portion, not FAB portion

  • Cm and Cd closes

  • Cm and Cd spliced out; B starts to make Cy (IgG), Ca, Ce

IgM

_arrow-up-right..

  • Classical pathway: 2 C1 molecules bind together to Fc of IgM; easy to bind because so many IgM Fc together

  • Prevents attachment: very large and clumps on to pathogens

  • Weak opsonin: too big; macrophages can't get to Fc

IgG

_arrow-up-right..

  • macrophages bind to Fc very easily

IgA

_arrow-up-right..

  • secretory component in middle of 2 IgA

  • linked by secretory: can't complement

IgA Protease

_arrow-up-right..

IgE

_arrow-up-right..

Somatic Hypermutation

_arrow-up-right..

  • Happens during proliferation after activation

  • Stronger binding will proliferate the most

B Cell Fate

_arrow-up-right..

Development Timeline

_arrow-up-right..

Vaccines

_arrow-up-right..

  • active

  • passive

Active

_arrow-up-right..

_arrow-up-right..

  • Live attenuated: T cell mediated response

  • Killed: antibodies against HA antigens of virus

  • Inactivated viral vaccines do not infect host cells and therefore do not enter the MHC class I antigen-processing pathway, which is normally required for the generation of a significant CD8+ cell-mediated immune response. In contrast, live-attenuated viral vaccines strongly stimulate the MHC class I antigen-processing pathway and can generate cytotoxic CD8+ T lymphocytes that kill infected cells.

_arrow-up-right..

Passive

_arrow-up-right..

  • give if suspicion for rabies, tetanus: neutralize before infection happens

Last updated